Technology sourcing acquisitions
Tóm tắt
The purpose of this paper is to determine what the effects of acquisition are on R&D patterns.
This paper tests whether the actual post‐acquisition R&D intensity of the combined firm deviated from the predicted R&D intensity, where the predicted amount is an asset‐weighted average of pre‐acquisition values.
The results indicate that the combination of technology sourcing and technological relatedness have strong predictive powers for determining changes in post‐acquisition R&D intensity. Technology sourcing acquisition of unrelated technologies results in an increase in post‐acquisition R&D intensity, as predicted. Acquirers in this situation may be using their acquisition as a platform for research expansion.
The dataset used in this paper was restricted to public acquirers and targets for completeness of financial information. It would be useful to determine the extent to which a technology sourcing acquirer is predicted to enter into an acquisition and also whether technology sourcing can be used as a predictor for the ultimate target company out of a pool of potential targets.
The results can be used to inform managers on a strategic level when research strategy deviates from what the theory would predict. For example, if a company that did a technology sourcing acquisition of an unrelated product subsequently decreased R&D intensity, then rival pharmaceutical firms can ascertain that the acquired research was ultimately determined to be too risky or unviable.
The value in this paper is the unique measurement for technology sourcing.
Từ khóa
Tài liệu tham khảo
Ahuja, G. and Katila, R. (2001), “Technological acquisitions and the innovation performance of acquiring firms: a longitudinal study”, Strategic Management Journal, Vol. 22 No. 3, pp. 197‐220.
Anand, J. and Kogut, B. (1997), “Technological capabilities of countries, firm rivalry and foreign direct investment”, Journal of International Business Studies, Vol. 28 No. 3, pp. 445‐65.
Andrade, G., Mitchell, M. and Stafford, E. (2001), “New evidence and perspectives on mergers”, Journal of Economic Perspectives, Vol. 15 No. 2, pp. 103‐20.
Beneito, P. (2006), “The innovative performance of in‐house and contracted R&D in terms of patents and utility models”, Research Policy, Vol. 35, pp. 502‐17.
Blonigen, B. and Taylor, C. (2000), “R&D intensity and acquisitions and high technology industries: evidence from the US electronic and electrical equipment industries”, Journal of Industrial Economics, Vol. 48, pp. 47‐70.
Bower, J.L. (2001), “Not all M&As are alike – and that matters”, Harvard Business Review, March, pp. 93‐101.
Capron, L. and Shen, J.C. (2007), “Acquisitions of private vs. public firms: private information, target selection and acquirer returns”, Strategic Management Journal, Vol. 28 No. 9, pp. 891‐911.
Cassiman, B., Colombo, M., Garrone, P. and Veugelers, R. (2005), “The impact of M&A on the R&D process: an empirical analysis of the role of technological‐ and market‐relatedness”, Research Policy, No. 34, pp. 195‐220.
Chaudhuri, S. and Tabrizi, B. (1999), “Capturing the real value in high‐tech acquisitions”, Harvard Business Review, Vol. 77 No. 5, pp. 123‐30.
Chung, W. and Alcacer, J. (2002), “Knowledge seeking and location choice of foreign direct investment in the United States”, Management Science, Vol. 48 No. 12, pp. 1534‐54.
Cohen, W.M. and Levinthan, D.A. (1990), “Absorptive capacity: a new perspective on learning and innovation”, Administrative Science Quarterly, Vol. 35, pp. 128‐52.
Crepon, B. and Duguet, E. (1997), “Research and development, competition and innovation pseudo‐maximum likelihood and simulated maximum likelihood methods applied to count data models with heterogeneity”, Journal of Econometrics, Vol. 79, pp. 355‐78.
DeCarolis, D. and Deeds, D. (1999), “The impact of stocks and flows of organizational knowledge on firm performance: an empirical investigation of the biotechnology industry”, Strategic Management Journal, Vol. 20 No. 10, pp. 953‐68.
Deloitte Consulting (2006), Bolstering Pipelines: Why Big Pharma and Biotechs Need Each Other, Deloitte & Touche USA LLP, New York, NY.
Ernst & Young (2006), Beyond Borders: Global Biotechnology Report 2006, Ernst & Young, Palo Alto, CA.
Fiegenbaum, A. and Thomas, H. (1988), “Attitudes toward risk and the risk‐return paradox: prospect theory explanations”, Academy of Management Journal, Vol. 31, pp. 85‐106.
Garcia‐Vega, M. (2006), “Does technological diversification promote innovation? An Empirical Analysis for European Firms”, Research Policy, Vol. 35, pp. 230‐46.
Granstrand, O. and Sjolander, S. (1990), “The acquisition of technology and small firms by large firms”, Journal of Economic Behavior and Organization, Vol. 13, pp. 367‐87.
Hall, B. (1987), “The effect of takeover activity on corporate research and development”, in Auerbach, A. (Ed.), Corporate Takeovers: Causes and Consequences, University of Chicago, Chicago, IL, March.
Hall, B. (1990), “The impact of corporate restructuring on industrial research and development”, Brookings Paper on Economic Activity, pp. 85‐135.
Hall, B., Griliches, Z. and Hausman, J. (1986), “R&D and patents? Is there a lag?”, International Economic Review, Vol. 27, pp. 265‐83.
Hall, B.H., Jaffe, A.B. and Tratjenberg, M. (2001), “The NBER patent citation data file: lessons, insights and methodological tools”, Working Paper 8498, NBER, Cambridge, MA.
Harrison, J.S., Hitt, M.A., Hoskisson, R.E. and Ireland, R.D. (1991), “Synergies and post‐acquisition performance: differences versus similarities in resource allocations”, Journal of Management, Vol. 17 No. 1, pp. 173‐90.
Hausman, J., Hall, B.H. and Griliches, Z. (1984), “Econometric models for count data with and application to the patents‐R&D relationship”, Econometrica, Vol. 52 No. 4, pp. 354‐83.
Higgins, M. and Rodriguez, D. (2006), “The outsourcing of R&D through acquisitions in the pharmaceutical industry”, Journal of Financial Economics, Vol. 80, pp. 351‐83.
Hitt, M., Hoskisson, R., Ireland, R. and Harrison, J. (1991), “Effects of acquisitions on R&D inputs and outputs”, Academy of Management Journal, Vol. 34 No. 3, pp. 693‐706.
Homburg, C. and Bucerius, M. (2005), “A marketing perspective on mergers and acquisitions: how marketing integration affects postmerger performance”, Journal of Marketing, Vol. 69, pp. 95‐113.
Homburg, C. and Bucerius, M. (2006), “Is speed of integration really a success factor of mergers and acquisitions?An analysis of the role of internal and external relatedness”, Strategic Management Journal, Vol. 27, pp. 347‐67.
Kamien, M. and Schwartz, N. (1982), Market Structure and Innovation, Cambridge University Press, Cambridge.
Kapoor, R. and Lim, K. (2007), “The impact of acquisitions on the productivity of inventors at semiconductor firms: a synthesis of knowledge‐based and incentive‐based perspectives”, Academy of Management Journal, Vol. 50 No. 5, pp. 1133‐55.
Kogut, B. and Chang, S. (1991), “Technological capabilities and Japanese foreign direct investment in the US”, Review of Economics and Statistics, Vol. 73, pp. 401‐13.
Kuemmerle, W. (1999), “The drivers of foreign direct investment into research and development: an empirical investigation”, Journal of International Business Studies, Vol. 30, pp. 1‐24.
Mitchell, D. (1989), “The importance of speed in post‐merger reorganization”, M&A Europe, Vol. 1 No. 3, pp. 44‐8.
Neven, D. and Siotis, G. (1996), “Technology sourcing and FDI in the EC: an empirical evaluation”, International Journal of Industrial Organization, Vol. 14, pp. 543‐60.
Pakes, A. and Griliches, Z. (1984), “Patents and R&D at the firm level: a first look”, in Griliches, Z. (Ed.), R&D, Patents and Productivity, University of Chicago Press, Chicago, IL, pp. 55‐72.
Prabhu, J., Chandy, R. and Ellis, M. (2005), “The impact of acquisitions on innovation: poison pill, placebo or tonic”, Journal of Marketing, No. 69, pp. 114‐30.
Rothaermel, F. and Deeds, D. (2004), “Exploration and exploitation alliances in biotechnology: a system of new product development”, Strategic Management Journal, Vol. 35 No. 3, p. 201.
Ruckman, K. (2005), “Technology sourcing through acquisitions: evidence from the US drug industry”, Journal of International Business Studies, Vol. 36 No. 1, pp. 89‐103.
Ruckman, K. (2007), “Acquiring biopharmaceutical research: is market approval a deal breaker?”, in Cooper, G. and Finkelstein, S. (Eds), Advances in Mergers and Acquisitions, Elsevier JAI Press, Oxford.
Schumpeter, J. (1961), Theory of Economic Development, Oxford University Press, New York, NY.
Schweizer, L. (2005), “Organizational Integration of acquired biotechnology companies into pharmaceutical companies: the need for a hybrid approach”, Academy of Management Journal, Vol. 48 No. 6, pp. 1051‐74.
Shan, W. and Song, J. (1997), “Foreign direct investment and the sourcing of technological advantage: evidence from the biotechnology industry”, Journal of International Business Studies, Vol. 28 No. 2, pp. 267‐83.
Veugelers, R. (1997), “Internal R&Dexpenditures and external technology sourcing”, Research Policy, Vol. 26, pp. 303‐15.